Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer Tamoxifen, which is ...
SAN ANTONIO ― Oncologists can now offer postmenopausal women with ductal carcinoma in situ (DCIS) two options for prevention of breast cancer recurrence: anastrozole (Arimidex, AstraZeneca ...
HER2/neu expression to be determined by quality-controlled assays using immunohistochemistry or FISH analysis. ER: Estrogen receptor; PgR: Progesterone receptor ...
Dec. 10 -- A new class of breast cancer drugs shows promise in the treatment of breast cancer and may bring new hope to women with both early- and advanced-stage cancers. Two drugs — anastrazole and ...
On the basis of these results, this study estimated the cost-effectiveness of anastrozole vs tamoxifen, from the perspective of the UK National Health Service NHS. Utility scores for a number of ...
CHICAGO, Dec 14 (Reuters) - Women who took AstraZeneca Plc's breast cancer drug Arimidex fared better than those who took the pill tamoxifen even four years after they stopped taking it, researchers ...
Women now have another drug they can take to prevent breast cancer from returning after surgery to remove the tumor. The federal Food and Drug Administration on Wednesday approved a new use for Femara ...
CHICAGO, Dec 14 (Reuters) - Women who took AstraZeneca Plc's breast cancer drug Arimidex fared better than those who took the pill tamoxifen even four years after they stopped taking it, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback